Epithelial to mesenchymal transition might be induced via CD44 isoform switching in colorectal cancer

Journal of Surgical Oncology

Volumn 110, Issue 6, 2014, Pages 745-751

  Mashita, Naoki ^a   Yamada, Suguru ^a   Nakayama, Goro ^a   Tanaka, Chie ^a   Iwata, Naoki ^a   Kanda, Mitsuro ^a   Kobayashi, Daisuke ^a   Fujii, Tsutomu ^a   Sugimoto, Hiroyuki ^a   Koike, Masahiko ^a   Nomoto, Shuji ^a   Fujiwara, Michitaka ^a   Kodera, Yasuhiro ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

CD44; Colorectal cancer; Epithelial to mesenchymal transition

Indexed keywords

CD44 VARIANT 9; CD44V ANTIGEN; HERMES ANTIGEN; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; CADHERIN; CD44 PROTEIN, HUMAN; ISOPROTEIN;

ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL LINE; CANCER PROGNOSIS; CANCER SURVIVAL; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HISTOLOGY; HUMAN; HUMAN CELL; INCIDENCE; LYMPH VESSEL; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PROTEIN EXPRESSION; VERY ELDERLY; CELL MOTION; COLLOID CARCINOMA; COLORECTAL TUMOR; GENETICS; LIVER TUMOR; LYMPH NODE METASTASIS; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PATHOPHYSIOLOGY; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; SECONDARY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE; YOUNG ADULT;

ADENOCARCINOMA, MUCINOUS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD44; CADHERINS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLORECTAL NEOPLASMS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROTEIN ISOFORMS; REAL-TIME POLYMERASE CHAIN REACTION; VIMENTIN; YOUNG ADULT;

EID: 84911998199     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23705     Document Type: Article

References (36)

1. Thompson EW, Newgreen DF: Carcinoma invasion and metastasis: A role for epithelial-mesenchymal transition? Cancer Res 2005;65: 5991-5995.
2. Thiery JP: Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002;2:442-454.
3. Thiery JP, Sleeman JP: Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 2006;7:131-142.
4. Thiery JP, Acloque H, Huang RY, et al.: Epithelial-mesenchymal transitions in development and disease. Cell 2009;139:871-890.
5. Micalizzi DS, Farabaugh SM, Ford HL: Epithelial-mesenchymal transition in cancer: Parallels between normal development and tumor progression. J Mammary Gland Biol Neoplasia 2010;15: 117-134.
6. Yang J, Mani SA, Donaher JL, et al.: Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004;117:927-939.
7. Kalluri R, Weinberg RA: The basics of epithelial-mesenchymal transition. J Clin Invest 2009;119:1420-1428.
8. Roy HK, Smyrk TC, Koetsier J, et al.: The transcriptional repressor SNAIL Is overexpressed in human colon cancer. Dig Dis Sci 2005;50:42-46.
9. Shioiri M, Shida T, Koda K, et al.: Slug expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients. Br J Cancer 2006;94:1816-1822.
10. Singh AB, Sharma A, Smith JJ, et al.: Claudin-1 up-regulates the repressor ZEB-1 to inhibit E-cadherin expression in colon cancer cells. Gastroenterology 2011;141:2140-2153.
11. Ono H, Imoto I, Kozaki K, et al.: SIX1 promotes epithelial-mesenchymal transition in colorectal cancer through ZEB1 activation. Oncogene 2012;31:4923-4934.
12. Kahlert C, Lahes S, Radhakrishnan P, et al.: Overexpression of ZEB2 at the invasion front of colorectal cancer is an independent prognostic marker and regulates tumor invasion in vitro. Clin Cancer Res 2011;17:7654-7663.
13. Mani SA, Guo W, Liao MJ, et al.: The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008;133:704-715.
14. Zoller M: CD44: Can a cancer-initiating cell profit from an abundantly expressed molecule? Nat Rev Cancer 2011;11:254-267.
15. Ponta H, Sherman L, Herrlich PA: CD44: From adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol 2003;4:33-45.
16. Naor D, Sionov RV, Ish-Shalom D: CD44: Structure, function, and association with the malignant process. Adv Cancer Res 1997; 71:241-319.
17. Uchino M, Kojima H, Wada K, et al.: Nuclear beta-catenin and CD44 upregulation characterize invasive cell populations in non-aggressive MCF-7 breast cancer cells. BMC Cancer 2010; 10:414.
18. Brown RL, Reinke LM, Damerow MS, et al.: CD44 splice isoform switching in human and mouse epithelium is essential for epithelialmesenchymal transition and breast cancer progression. J Clin Invest 2011;121:1064-1074.
19. Mima K, Okabe H, Ishimoto T, et al.: CD44s regulates the TGF-beta-mediated mesenchymal phenotype and is associated with poor prognosis in patients with hepatocellular carcinoma. Cancer Res 2012;72:3414-3423.
20. Tanabe KK, Ellis LM, Saya H: Expression of CD44R1 adhesion molecule in colon carcinomas and metastases. Lancet 1993;341: 725-726.
21. Ishimoto T, Nagano O, Yae T, et al.: CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth. Cancer Cell 2011;19: 387-400.
22. Yae T, Tsuchihashi K, Ishimoto T, et al.: Alternative splicing of CD44 mRNA by ESRP1 enhances lung colonization of metastatic cancer cell. Nat Commun 2012;3:883.
23. Hwang WL, Yang MH, Tsai ML, et al.: SNAIL regulates interleukin-8 expression, stem cell-like activity, and tumorigenicity of human colorectal carcinoma cells. Gastroenterology 2011;141: 279-291 291.e1-e5.
24. Fan F, Samuel S, Evans KW, et al.: Overexpression of Snail induces epithelial-mesenchymal transition and a cancer stem cell-like phenotype in human colorectal cancer cells. Cancer Med 2012;1: 5-16.
25. Cho SH, Park YS, Kim HJ, et al.: CD44 enhances the epithelialmesenchymal transition in association with colon cancer invasion. Int J Oncol 2012;41:211-218.
26. Ye J, Wu D, Shen J, et al.: Enrichment of colorectal cancer stem cells through epithelial-mesenchymal transition via CDH1 knockdown. Mol Med Rep 2012;6:507-512.
27. Chen X, Wang Y, Xia H, et al.: Loss of E-cadherin promotes the growth, invasion and drug resistance of colorectal cancer cells and is associated with liver metastasis. Mol Biol Rep 2012;39: 6707-6714.
28. He X, Chen Z, Jia M, et al.: Downregulated E-cadherin expression indicates worse prognosis in Asian patients with colorectal cancer: Evidence from meta-analysis. PLoS ONE 2013;8:e70858.
29. Yamada S, Fuchs BC, Fujii T, et al.: Epithelial-to-mesenchymal transition predicts prognosis of pancreatic cancer. Surgery 2013;154:946-954.
30. Murai T, Yamada S, Fuchs BC, et al.: Epithelial-to-mesenchymal transition predicts prognosis in clinical gastric cancer. J Surg Oncol 2014;109:684-689.
31. Klingbeil P, Isacke CM: The 'alternative' EMT switch. Breast Cancer Res 2011;13:313.
32. Kunimura T, Yoshida T, Sugiyama T, et al.: The relationships between loss of standard CD44 expression and lymph node, liver metastasis in T3 colorectal carcinoma. J Gastrointest Cancer 2009; 40:115-118.
33. Fernandez JC, Vizoso FJ, Corte MD, et al.: CD44s expression in resectable colorectal carcinomas and surrounding mucosa. Cancer Invest 2004;22:878-885.
34. Bendardaf R, Algars A, Elzagheid A, et al.: Comparison of CD44 expression in primary tumours and metastases of colorectal cancer. Oncol Rep 2006;16:741-746.
35. Asao T, Nakamura J, Shitara Y, et al.: Loss of standard type of CD44 expression in invaded area as a good indicator of lymph-node metastasis in colorectal carcinoma. Dis Colon Rectum 2000;43: 1250-1254, discussion 1254-1255.
36. Huh JW, Kim HR, Kim YJ, et al.: Expression of standard CD44 in human colorectal carcinoma: Association with prognosis. Pathol Int 2009;59:241-246.